P47869 GBRA2_HUMAN
Gene name: GABRA2
Protein name: Gamma-aminobutyric acid receptor subunit alpha-2
List of molecules and drugs that target protein P47869
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P47869_DB00241 | DB00241 | Butalbital | potentiator | UZVHFVZFNXBMQJ-UHFFFAOYSA-N | CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O | |
2 | P47869_DB00306 | DB00306 | Talbutal | potentiator | BJVVMKUXKQHWJK-UHFFFAOYSA-N | CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O | |
3 | P47869_DB00312 | DB00312 | Pentobarbital | potentiator | EC50(nM) = 50000.0 | WEXRUCMBJFQVBZ-UHFFFAOYSA-N | CCCC(C)C1(CC)C(=O)NC(=O)NC1=O |
4 | P47869_DB00371 | DB00371 | Meprobamate | agonist | NPPQSCRMBWNHMW-UHFFFAOYSA-N | CCCC(C)(COC(N)=O)COC(N)=O | |
5 | P47869_DB00402 | DB00402 | Eszopiclone | agonist | GBBSUAFBMRNDJC-INIZCTEOSA-N | CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1 | |
6 | P47869_DB00418 | DB00418 | Secobarbital | potentiator | KQPKPCNLIDLUMF-UHFFFAOYSA-N | CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O | |
7 | P47869_DB00425 | DB00425 | Zolpidem | agonist | Ki(nM) = 103.0 EC50(nM) = 737.0 | ZAFYATHCZYHLPB-UHFFFAOYSA-N | CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1 |
8 | P47869_DB00463 | DB00463 | Metharbital | potentiator | FWJKNZONDWOGMI-UHFFFAOYSA-N | CCC1(CC)C(=O)NC(=O)N(C)C1=O | |
9 | P47869_DB00599 | DB00599 | Thiopental | potentiator | IUJDSEJGGMCXSG-UHFFFAOYSA-N | CCCC(C)C1(CC)C(=O)NC(=S)NC1=O | |
10 | P47869_DB00794 | DB00794 | Primidone | potentiator | DQMZLTXERSFNPB-UHFFFAOYSA-N | CCC1(C(=O)NCNC1=O)C1=CC=CC=C1 | |
11 | P47869_DB00849 | DB00849 | Methylphenobarbital | potentiator | ALARQZQTBTVLJV-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1 | |
12 | P47869_DB00898 | DB00898 | Ethanol | n/a | LFQSCWFLJHTTHZ-UHFFFAOYSA-N | CCO | |
13 | P47869_DB01198 | DB01198 | Zopiclone | potentiator | GBBSUAFBMRNDJC-UHFFFAOYSA-N | CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1 | |
14 | P47869_DB01346 | DB01346 | Quinidine barbiturate | potentiator | YHRUERMOPBDCFD-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C | |
15 | P47869_DB01351 | DB01351 | Amobarbital | potentiator | VIROVYVQCGLCII-UHFFFAOYSA-N | CCC1(CCC(C)C)C(=O)NC(=O)NC1=O | |
16 | P47869_DB01352 | DB01352 | Aprobarbital | potentiator | UORJNBVJVRLXMQ-UHFFFAOYSA-N | CC(C)C1(CC=C)C(=O)NC(=O)NC1=O | |
17 | P47869_DB01353 | DB01353 | Butobarbital | potentiator | STDBAQMTJLUMFW-UHFFFAOYSA-N | CCCCC1(CC)C(=O)NC(=O)NC1=O | |
18 | P47869_DB01354 | DB01354 | Heptabarbital | potentiator | PAZQYDJGLKSCSI-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1 | |
19 | P47869_DB01355 | DB01355 | Hexobarbital | potentiator | UYXAWHWODHRRMR-UHFFFAOYSA-N | CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1 | |
20 | P47869_DB01483 | DB01483 | Barbital | potentiator | FTOAOBMCPZCFFF-UHFFFAOYSA-N | CCC1(CC)C(=O)NC(=O)NC1=O | |
21 | P47869_DB01496 | DB01496 | Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione | potentiator | DNZPLHRZXUJATK-UHFFFAOYSA-N | FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1 | |
22 | P47869_DB01567 | DB01567 | Fludiazepam | potentiator | ROYOYTLGDLIGBX-UHFFFAOYSA-N | CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F | |
23 | P47869_DB04903 | DB04903 | Pagoclone | n/a | HIUPRQPBWVEQJJ-UHFFFAOYSA-N | CC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1 | |
24 | P47869_DB13994 | DB13994 | AZD-7325 | positive allosteric modulator | KYDURMHFWXCKMW-UHFFFAOYSA-N | CCCNC(=O)C1=C(N)C2=CC=CC(=C2N=N1)C1=C(F)C=CC=C1OC |